Literature DB >> 11753086

Kidney ischemic preconditioning.

Joseph V Bonventre1.   

Abstract

Ischemic injury to the kidney is associated with high morbidity and mortality. Improving the ability of the kidney to tolerate ischemic injury would have important implications. A significant amount of data now exists to suggest that there may be intrinsic mechanisms brought to bear by the kidney when exposed to a toxic or ischemic insult, which protect it against a subsequent exposure to ischemia. While it is frequently stated that this phenomenon, termed ischemic preconditioning, was first described in the heart, in fact there is almost a century of literature on the kidney that supports the concept that prior injury protects against a second insult. The protective effect of preconditioning is greater than most reported protective effects with pharmacological interventions in animals. There is compelling evidence in other organs that preconditioning occurs in humans. It therefore behooves us to understand the endogenous processes that the kidney has developed to protect itself against an ischemic insult. Armed with this understanding we can then attempt to mimic these processes and thereby prevent and treat ischemic acute renal failure.

Entities:  

Mesh:

Year:  2002        PMID: 11753086     DOI: 10.1097/00041552-200201000-00007

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  54 in total

Review 1.  [Myocardial preconditioning with volatile anesthetics. General anesthesia as protective intervention?].

Authors:  H Buchinger; U Grundmann; S Ziegeler
Journal:  Anaesthesist       Date:  2005-09       Impact factor: 1.041

2.  Activation of hypoxia-inducible factor-1 ameliorates postischemic renal injury via inducible nitric oxide synthase.

Authors:  Xiao-Li Zhang; Zhen-Wen Yan; Wei-Wen Sheng; Jing Xiao; Zhen-Xing Zhang; Zhi-Bin Ye
Journal:  Mol Cell Biochem       Date:  2011-07-14       Impact factor: 3.396

Review 3.  Regulatory T cells in AKI.

Authors:  Gilbert R Kinsey; Rahul Sharma; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2013-10-17       Impact factor: 10.121

4.  Aberrant tubuloglomerular feedback and HIF-1α confer resistance to ischemia after subtotal nephrectomy.

Authors:  Prabhleen Singh; Roland C Blantz; Christian Rosenberger; Francis B Gabbai; Trenton R Schoeb; Scott C Thomson
Journal:  J Am Soc Nephrol       Date:  2012-01-19       Impact factor: 10.121

5.  Limb ischemia protects against contrast-induced nephropathy.

Authors:  Joseph V Bonventre
Journal:  Circulation       Date:  2012-06-26       Impact factor: 29.690

Review 6.  miR-21 in ischemia/reperfusion injury: a double-edged sword?

Authors:  Xialian Xu; Alison J Kriegel; Xiaoyan Jiao; Hong Liu; Xiaowen Bai; Jessica Olson; Mingyu Liang; Xiaoqiang Ding
Journal:  Physiol Genomics       Date:  2014-08-26       Impact factor: 3.107

7.  Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury.

Authors:  Karl A Nath; Joseph P Grande; Anthony J Croatt; Elena Frank; Noel M Caplice; Robert P Hebbel; Zvonimir S Katusic
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

8.  JAK2/Y343/STAT5 signaling axis is required for erythropoietin-mediated protection against ischemic injury in primary renal tubular epithelial cells.

Authors:  A C Breggia; D M Wojchowski; J Himmelfarb
Journal:  Am J Physiol Renal Physiol       Date:  2008-09-24

9.  Preexisting chronic kidney disease: a potential for improved outcomes from acute kidney injury.

Authors:  Nitin Khosla; Sharon B Soroko; Glenn M Chertow; Jonathan Himmelfarb; T Alp Ikizler; Emil Paganini; Ravindra L Mehta
Journal:  Clin J Am Soc Nephrol       Date:  2009-11-25       Impact factor: 8.237

10.  Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model.

Authors:  W M Bernhardt; U Gottmann; F Doyon; B Buchholz; V Campean; J Schödel; A Reisenbuechler; S Klaus; M Arend; L Flippin; C Willam; M S Wiesener; B Yard; C Warnecke; K-U Eckardt
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.